Clinical Trial Update: IVIG Treatment in Systemic Sclerosis [NA]

View source ↗

Summary

Clinical trial update on intravenous immunoglobulin (IVIG) treatment for systemic sclerosis, including the diffuse cutaneous form; the trial status is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Systemic Sclerosis

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Georgetown University | Conditions: Systemic Sclerosis, Diffuse Scleroderma | NA | Status: UNKNOWN